Nia Health

Nia is the firNia Health is the first comprehensive support for atopic dermatitis patients. The app Nia is equipped with artificial intelligence, which offers atopic dermatitis patients digital st comprehensive support for atopic dermatitis patients.

Nia Health develops and markets a service platform for eczema patients. The core product is the smartphone app Nia, which supports patients and their relatives in their daily dealings with the most common chronic skin disease by offering them holistic, digital support. The medically validated content and personalized functions of Nia make people active creators of their health and help them to improve their quality of life.

Around half of those affected are children. Thus, young mothers of affected children in particular seek support and are characterized by a high level of suffering.

Nia Health addresses this need and offers its target group an app as a personal coach. Giving those affected a medically validated and personalized source of information enables sustainable relief from the burdensome symptoms of illness. The next (digital) visit to the doctor can be documented and prepared with Nia. It enables personalized treatment plans, reduces medical costs and avoids doctor-hopping.

Nia Health's holistic approach goes beyond the classic diary functions of other providers and integrates physicians directly into the service. This approach provides the following USPs for the platform: 1. highly personalized treatment plans for people affected by atopic dermatitis, 2. a comprehensive range of services covering all functionalities to guarantee users the best possible support, and 3. user experience oriented to the actual user needs. The innovative software implementation of these features as well as the personalization of treatment plans by methods of artificial intelligence are the core intellectual properties of the company, which can only be copied by costly and time consuming reverse engineering. Besides, our cooperation with the AGNES e.V. safeguards us access to their clinically proven curriculum, which is currently the gold standard for atopic dermatitis treatment.